Literature DB >> 25133435

Breast cancer risk and use of calcium channel blockers using Swedish population registries.

Gudrun Jonasdottir Bergman1, Staffan Khan1, Bengt Danielsson1, Natalia Borg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25133435     DOI： 10.1001/jamainternmed.2014.3867

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  6 in total

1.  Antihypertensive medication use and incident breast cancer in women.

Authors:  Elizabeth E Devore; Sung Kim; Cody A Ramin; Lani R Wegrzyn; Jennifer Massa; Michelle D Holmes; Karin B Michels; Rulla M Tamimi; John P Forman; Eva S Schernhammer
Journal:  Breast Cancer Res Treat       Date:  2015-02-21       Impact factor: 4.872

2.  Antihypertensive medication use and ovarian cancer survival.

Authors:  Tianyi Huang; Mary K Townsend; Robert L Dood; Anil K Sood; Shelley S Tworoger
Journal:  Gynecol Oncol       Date:  2021-09-21       Impact factor: 5.482

3.  Calcium Channel Blocker Use and the Risk for Breast Cancer: A Population-Based Nested Case-Control Study.

Authors:  Victoria Rotshild; Bruria Hirsh Raccah; Muna Gazawe; Ilan Matok
Journal:  Cancers (Basel)       Date:  2022-05-09       Impact factor: 6.575

4.  Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women.

Authors:  Lauren E Wilson; Aimee A D'Aloisio; Dale P Sandler; Jack A Taylor
Journal:  Breast Cancer Res       Date:  2016-07-05       Impact factor: 6.466

5.  Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD).

Authors:  Lamiae Grimaldi-Bensouda; Olaf Klungel; Xavier Kurz; Mark C H de Groot; Ana S Maciel Afonso; Marie L de Bruin; Robert Reynolds; Michel Rossignol
Journal:  BMJ Open       Date:  2016-01-08       Impact factor: 2.692

Review 6.  CaV channels and cancer: canonical functions indicate benefits of repurposed drugs as cancer therapeutics.

Authors:  Paul J Buchanan; Karen D McCloskey
Journal:  Eur Biophys J       Date:  2016-06-24       Impact factor: 1.733
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.